Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 48:89-96, doi:10.1016/j.jacc.2006.01.077 (Published online 9 June 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.01.077v1
48/1/89    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by López, B.
Right arrow Articles by Díez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by López, B.
Right arrow Articles by Díez, J.

CLINICAL RESEARCH: HEART FAILURE

Alterations in the Pattern of Collagen Deposition May Contribute to the Deterioration of Systolic Function in Hypertensive Patients With Heart Failure

Begoña López, PhD*, Arantxa González, PhD*, Ramón Querejeta, MD, PhD{dagger}, Mariano Larman, MD{ddagger} and Javier Díez, MD, PhD*,§,*

* Division of Cardiovascular Sciences, Centre for Applied Medical Research, School of Medicine, University of Navarra, Pamplona, Spain
{dagger} Division of Cardiology, Donostia University Hospital, San Sebastián, Spain
{ddagger} Division of Hemodynamics, Guipúzcoa Polyclinics, San Sebastián, Spain
§ Department of Cardiology and Cardiovascular Surgery, University Clinic, University of Navarra, Pamplona, Spain.

Manuscript received November 10, 2005; revised manuscript received December 23, 2005, accepted January 16, 2006.

* Reprint requests and correspondence: Dr. Javier Díez, Área de Ciencias Cardiovasculares, CIMA, Pío XII 55, 31008 Pamplona, Spain. (Email: jadimar{at}unav.es).

OBJECTIVES: We sought to assess the distribution of collagen deposits and collagen degradation in hypertensive patients with either systolic heart failure (SHF) or diastolic heart failure (DHF).

BACKGROUND: Increased collagen synthesis and deposition have been described in the myocardium of heart failure (HF) hypertensive patients.

METHODS: We studied 39 HF hypertensive patients subdivided into two groups: 16 with SHF and 23 with DHF. Endomyocardial biopsies were performed to quantify mysial (i.e., perimysial plus endomysial) and perivascular and scar-related collagen volume fraction (CVF). Matrix metalloproteinase (MMP)-1 and its tissue inhibitor matrix metalloproteinase (TIMP)-1 were analyzed in cardiac samples by Western blot and immunohistochemistry, and in blood samples by enzyme-linked immunosorbent assay.

RESULTS: Mysial CVF was lower in SHF hypertensive patients than in normotensive (p < 0.05) and DHF hypertensive patients (p < 0.01). Perivascular and scar-related CVF was higher (p < 0.05) in the two groups of hypertensive patients than in normotensive subjects, and in SHF hypertensive compared with DHF hypertensive patients. The MMP-1:TIMP-1 ratio was increased (p < 0.05) in tissue and serum samples from the SHF hypertensive group compared with the other two groups of subjects. The MMP-1 expression was increased (p < 0.01) in the interstitium and cardiomyocytes of SHF hypertensive patients compared with DHF hypertensive and normotensive subjects. The serum MMP-1:TIMP-1 ratio was inversely correlated with ejection fraction (r = –0.510, p < 0.001) and directly correlated with left ventricular end-diastolic diameter (r = 0.549, p < 0.001) in all subjects.

CONCLUSIONS: These findings show that the pattern of collagen deposits and the balance of the MMP-1/TIMP-1 system are different in the myocardium of SHF and DHF hypertensive patients. It is proposed that excessive degradation of mysial collagen may be related to the compromise of systolic function in HF hypertensive patients.

Abbreviations and Acronyms
  ADU = arbitrary densitometric unit
  CVF = collagen volume fraction
  DHF = diastolic heart failure
  EF = ejection fraction
  ELISA = enzyme-linked immunosorbent assay
  HF = heart failure
  LV = left ventricle/ventricular
  LVEDD = left ventricular end-diastolic diameter
  LVESWS = left ventricular end-systolic circumferential wall stress
  LVH = left ventricular hypertrophy
  LVMI = left ventricular mass index
  MMP = matrix metalloproteinase
  NT-proBNP = amino-terminal pro-brain natriuretic peptide
  SHF = systolic heart failure
  SHR = spontaneously hypertensive rat
  TIMP = tissue inhibitor matrix metalloproteinase




This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
Y.-C. Cheng, W.-H. L. Kao, B. D. Mitchell, J. R. O'Connell, H. Shen, P. F. McArdle, Q. Gibson, K. A. Ryan, A. R. Shuldiner, and T. I. Pollin
Genome-Wide Association Scan Identifies Variants near Matrix Metalloproteinase (MMP) Genes on Chromosome 11q21-22 Strongly Associated With Serum MMP-1 Levels
Circ Cardiovasc Genet, August 1, 2009; 2(4): 329 - 337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. S. De Silva, R. M. Wilson, C. Hutchinson, P. C. Ip, A. G. Garcia, S. Lancel, M. Ito, D. R. Pimentel, and F. Sam
Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1983 - H1993.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Gonzalez, B. Lopez, S. Ravassa, J. Beaumont, T. Arias, N. Hermida, A. Zudaire, and J. Diez
Biochemical markers of myocardial remodelling in hypertensive heart disease
Cardiovasc Res, February 15, 2009; 81(3): 509 - 518.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Hermida, B. Lopez, A. Gonzalez, J. Dotor, J. J. Lasarte, P. Sarobe, F. Borras-Cuesta, and J. Diez
A synthetic peptide from transforming growth factor-{beta}1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats
Cardiovasc Res, February 15, 2009; 81(3): 601 - 609.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Lopez, R. Querejeta, A. Gonzalez, J. Beaumont, M. Larman, and J. Diez
Impact of Treatment on Myocardial Lysyl Oxidase Expression and Collagen Cross-Linking in Patients With Heart Failure
Hypertension, February 1, 2009; 53(2): 236 - 242.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. L. Muiesan, M. Salvetti, A. Paini, C. Agabiti-Rosei, C. Monteduro, G. Galbassini, E. Belotti, C. Aggiusti, D. Rizzoni, M. Castellano, et al.
Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism
Hypertension, September 1, 2008; 52(3): 529 - 534.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. A. Helm, P. Caravan, B. A. French, V. Jacques, L. Shen, Y. Xu, R. J. Beyers, R. J. Roy, C. M. Kramer, and F. H. Epstein
Postinfarction Myocardial Scarring in Mice: Molecular MR Imaging with Use of a Collagen-targeting Contrast Agent
Radiology, June 1, 2008; 247(3): 788 - 796.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. Garcia-Bolao, B. Lopez, A. Macias, J. J. Gavira, P. Azcarate, and J. Diez
Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy
Eur. Heart J., April 1, 2008; 29(7): 898 - 906.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Lopez, A. Gonzalez, J. Beaumont, R. Querejeta, M. Larman, and J. Diez
Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients With Chronic Heart Failure
J. Am. Coll. Cardiol., August 28, 2007; 50(9): 859 - 867.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. L. Muiesan, M. Salvetti, A. Paini, C. Monteduro, G. Galbassini, B. Bonzi, P. Poisa, E. Belotti, C. Agabiti Rosei, D. Rizzoni, et al.
Inappropriate Left Ventricular Mass Changes During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients
Hypertension, May 1, 2007; 49(5): 1077 - 1083.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. S.P. Lam, V. L. Roger, R. J. Rodeheffer, F. Bursi, B. A. Borlaug, S. R. Ommen, D. A. Kass, and M. M. Redfield
Cardiac Structure and Ventricular-Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota
Circulation, April 17, 2007; 115(15): 1982 - 1990.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Martos, J. Baugh, M. Ledwidge, C. O'Loughlin, C. Conlon, A. Patle, S. C. Donnelly, and K. McDonald
Diastolic Heart Failure: Evidence of Increased Myocardial Collagen Turnover Linked to Diastolic Dysfunction
Circulation, February 20, 2007; 115(7): 888 - 895.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol., January 30, 2007; 49(4): 509 - 527.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Shirwany and K. T. Weber
Extracellular Matrix Remodeling in Hypertensive Heart Disease
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 97 - 98.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement